Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Return on Sales (2016 - 2025)

Bioadaptives' Return on Sales history spans 7 years, with the latest figure at 0.79% for Q4 2025.

  • On a quarterly basis, Return on Sales fell 27.0% to 0.79% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.89%, a 37.0% decrease, with the full-year FY2025 number at 0.85%, down 14.0% from a year prior.
  • Return on Sales hit 0.79% in Q4 2025 for Bioadaptives, up from 0.82% in the prior quarter.
  • Over the last five years, Return on Sales for BDPT hit a ceiling of 0.03% in Q4 2023 and a floor of 12.61% in Q1 2025.
  • Historically, Return on Sales has averaged 1.15% across 5 years, with a median of 0.51% in 2021.
  • The widest YoY moves for Return on Sales: up 222bps in 2025, down -1256bps in 2025.
  • Tracing BDPT's Return on Sales over 5 years: stood at 0.23% in 2021, then crashed by -200bps to 0.7% in 2022, then soared by 104bps to 0.03% in 2023, then tumbled by -2044bps to 0.52% in 2024, then plummeted by -53bps to 0.79% in 2025.
  • Business Quant data shows Return on Sales for BDPT at 0.79% in Q4 2025, 0.82% in Q3 2025, and 0.49% in Q2 2025.